Remove Drugs Remove Online Pharmacies Remove Research
article thumbnail

Statements and Thoughts on Motion on Summary Judgement in PharmacyChecker v. NABP et al 

Policy Prescription

the National Association of Boards of Pharmacy et al., in which PharmacyChecker alleges an unlawful “conspiracy involving front groups for Big Pharma” that keep “lower priced drugs out of reach of millions of Americans.” That research has identified PharmacyChecker as a company that properly credentials online pharmacies.

article thumbnail

CDER’s Office of Compliance Kicks Off Annual Report Season with Rundown of 2023’s Major Public Health Enforcement Initiatives

FDA Law Blog: Biosimilars

Claud — The Office of Compliance (OC) at FDA’s Center for Drug Evaluation and Research (CDER) had a role in many of the major public health enforcement matters you may have read about last year. OC devoted a lot of resources to its compliance efforts directed at human drug compounding. Drug Supply Chain. By John W.M.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Pharma-Funded Groups Lie About Personal Drug Imports

Policy Prescription

For the past decade, I’ve written extensively about my view that pharma-funded organizations and initiatives are responsible for misleading Americans about the safety of buying more affordable prescription drugs over the Internet for import from Canada and other countries. Here’s one example and you can be the judge.

article thumbnail

DOJ Investigates $250 Million in U.S. Sales of Counterfeit Drugs Using Fake DSCSA Pedigrees

Policy Prescription

Department of Justice, according to Seeking Alpha , is investigating the sale and distribution of counterfeit drugs in the U.S. drug supply chain consisting of $250 million in counterfeit HIV drugs that were sold throughout the U.S. from licensed pharmacies to American patients.